GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cantel Medical Corp (NYSE:CMD) » Definitions » Asset Turnover

Cantel Medical (Cantel Medical) Asset Turnover : 0.15 (As of Apr. 2021)


View and export this data going back to 1992. Start your Free Trial

What is Cantel Medical Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Cantel Medical's Revenue for the three months ended in Apr. 2021 was $314 Mil. Cantel Medical's Total Assets for the quarter that ended in Apr. 2021 was $2,041 Mil. Therefore, Cantel Medical's Asset Turnover for the quarter that ended in Apr. 2021 was 0.15.

Asset Turnover is linked to ROE % through Du Pont Formula. Cantel Medical's annualized ROE % for the quarter that ended in Apr. 2021 was 10.53%. It is also linked to ROA % through Du Pont Formula. Cantel Medical's annualized ROA % for the quarter that ended in Apr. 2021 was 4.14%.


Cantel Medical Asset Turnover Historical Data

The historical data trend for Cantel Medical's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantel Medical Asset Turnover Chart

Cantel Medical Annual Data
Trend Jul11 Jul12 Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.04 1.04 1.00 0.90 0.65

Cantel Medical Quarterly Data
Jul16 Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 0.12 0.14 0.14 0.15

Competitive Comparison of Cantel Medical's Asset Turnover

For the Medical Instruments & Supplies subindustry, Cantel Medical's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cantel Medical's Asset Turnover Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cantel Medical's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Cantel Medical's Asset Turnover falls into.



Cantel Medical Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Cantel Medical's Asset Turnover for the fiscal year that ended in Jul. 2020 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Jul. 2020 )/( (Total Assets (A: Jul. 2019 )+Total Assets (A: Jul. 2020 ))/ count )
=1016.048/( (1070.366+2071.754)/ 2 )
=1016.048/1571.06
=0.65

Cantel Medical's Asset Turnover for the quarter that ended in Apr. 2021 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Apr. 2021 )/( (Total Assets (Q: Jan. 2021 )+Total Assets (Q: Apr. 2021 ))/ count )
=313.953/( (2050.31+2031.278)/ 2 )
=313.953/2040.794
=0.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Cantel Medical  (NYSE:CMD) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Cantel Medical's annulized ROE % for the quarter that ended in Apr. 2021 is

ROE %**(Q: Apr. 2021 )
=Net Income/Total Stockholders Equity
=84.472/802.428
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(84.472 / 1255.812)*(1255.812 / 2040.794)*(2040.794/ 802.428)
=Net Margin %*Asset Turnover*Equity Multiplier
=6.73 %*0.6154*2.5433
=ROA %*Equity Multiplier
=4.14 %*2.5433
=10.53 %

Note: The Net Income data used here is four times the quarterly (Apr. 2021) net income data. The Revenue data used here is four times the quarterly (Apr. 2021) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Cantel Medical's annulized ROA % for the quarter that ended in Apr. 2021 is

ROA %(Q: Apr. 2021 )
=Net Income/Total Assets
=84.472/2040.794
=(Net Income / Revenue)*(Revenue / Total Assets)
=(84.472 / 1255.812)*(1255.812 / 2040.794)
=Net Margin %*Asset Turnover
=6.73 %*0.6154
=4.14 %

Note: The Net Income data used here is four times the quarterly (Apr. 2021) net income data. The Revenue data used here is four times the quarterly (Apr. 2021) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Cantel Medical Asset Turnover Related Terms

Thank you for viewing the detailed overview of Cantel Medical's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Cantel Medical (Cantel Medical) Business Description

Traded in Other Exchanges
N/A
Address
150 Clove Road, 9th Floor, Little Falls, NJ, USA, 07424
Cantel Medical is a New Jersey-based manufacturer of hospital supplies for infection prevention, which include products used in endoscope disinfection, water purification systems for use in dialysis treatment, and dental supplies. The firm reports in four segments: medical (46% of fiscal 2020 sales), dental (32%), life sciences (19%), and dialysis (3%). Geographic exposure is primarily in the U.S., which accounts for about 75% of revenue, with international markets making up the remaining 25%.
Executives
Ann E Berman director 255 STATE STREET, BOSTON MA 02109
Jeffrey Z Mann officer: SVP, General Counsel 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
George L Fotiades director, officer: Chief Executive Officer 281 SUMMIT AVENUE, SUMMIT NJ 07901
Charles M Diker director, 10 percent owner, officer: Chairman ONE NEW YORK PLAZA, NEW YORK NY 10004
Shaun M. Blakeman officer: SVP - CFO C/O CANTEL MEDICAL CORP., 150 CLOVE ROAD, LITTLE FALLS NJ 07424
Jean Casner officer: SVP and CHRO 150 CLOVE ROAD, LITTLE FALLS NJ 07424
Brian Capone officer: SVP and Princ. Accounting Ofr 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Peter G Clifford officer: President and COO 40 TOURNAMENT DRIVE SOUTH, HAWTHORN WOODS IL 60047
Seth M Yellin officer: Executive Vice President 150 CLOVE ROAD 9TH FLOOR LITTLE FALLS NJ 07424
Laura L Forese director 849 STONEWALL COURT FRANKLIN LAKES NJ 07417
Peter Pronovost director JHU-QSRG 1909 THAMES ST. - 2ND FLOOR BALTIMORE MD 21231
Anthony B Evnin director C/O VENROCK ASSOCIATES, 7 BRYANT PARK, 23RD FLOOR, NEW YORK NY 10018
Ronnie Myers director TOURO COLLEGE OF DENTAL MEDICINE 40 SUNSHINE COTTAGE ROAD VALHALLA NY 10595
Alan R Batkin director 399 PARK AVENUE, 10TH FLOOR, NEW YORK NY 10022
Karen Prange director 1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316